-
Post-DCE Qualitative Interviews: A Novel Method to Understand the Rationale for Stated Preferences - An Example Among Patients and Physicians in Severe Asthma
Mar 10, 2025, 14:00 PM -
How Have Canada's Drug Agency Guidelines Impacted Choice of Model Structure and Use of Partitioned Survival Models in Oncology Submissions?
Mar 10, 2025, 14:00 PM -
Estimation of Drug Cost Reductions by Introducing formularies for An Employment-based Health Insurance Plan : A Simulation Using “Wellness-Star☆” Health Insurance Claims Database
Mar 10, 2025, 14:00 PM -
Other Similar Measures? – How Different Really Are QALYs From Life Years, Health Years in Total, and Equal Value Life Years?
Mar 10, 2025, 14:00 PM -
Assessing Real-World Dosing Patterns for Vesicular Monoamine Transporter-2 Inhibitors (VMAT2i), Valbenazine and Deutetrabenazine, Among Patients with Tardive Dyskinesia (TD) in a Nationwide US Claims Database
Mar 10, 2025, 14:00 PM -
Unmet Needs and Evidence Gaps Among Patients with DLBCL treated with CAR-T Therapy: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Facilitating Effective Implementation of Qualitative in Trial Interviews
Mar 10, 2025, 14:00 PM -
Development of an Online Patient Decision Aid and Culturally Conscious Toolkit for Inflammatory Bowel Disease
Mar 10, 2025, 14:00 PM -
How Well Does Hospital Billing Data Estimate Readmissions and Revision Risks After Spinal Fusion Surgery, Compared to Hospital Billing Linked to Claims Data?
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab as Treatment for FIGO 2014 Stage III-IVA Cervical Cancer in the United States
Mar 10, 2025, 14:00 PM -
Molecular Profiling, Treatment (Tx) Patterns, and Healthcare Resource Utilization (HCRU) in United States Patients with Unresectable Locally Advanced/Metastatic Biliary Tract Cancer
Mar 10, 2025, 14:00 PM -
Frequently Asked Questions (FAQs): What Are the Risks and Mitigation Strategies in Using Gen-AI in HEOR?
Mar 10, 2025, 14:00 PM -
From AI to Experts: Understanding Pre-Election Inflation Narratives on Social Media via Sentiment and Topic Analysis
Mar 10, 2025, 14:00 PM -
Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies
Mar 10, 2025, 14:00 PM -
Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs
Mar 10, 2025, 14:00 PM -
The Economic Benefit of Biosimilars in North America: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Generalized Cost-Effectiveness Analysis with Dynamic Prevalence for Improving Health Equity Among Rare Diseases
Mar 10, 2025, 14:00 PM -
Access Disparities in Maintenance Medication among Patients with Mild Asthma
Mar 10, 2025, 14:00 PM -
How to Mitigate "Carer QALY Trap" when Including Caregiver QOL in Cost-Effectiveness Analysis: A Model Simulation Using Lecanemab in Japanese Patients with Alzheimer's Disease
Mar 10, 2025, 14:00 PM -
Economic and Health Care Resource Utilization (HCRU) Burden of Acute Myocardial Infarction (AMI) With or Without Systemic Inflammation in US Hospitals: A Real-World Study
Mar 10, 2025, 14:00 PM